Protalix BioTherapeutics Inc (PLX)
2.48
-0.05
(-1.98%)
USD |
NYAM |
Mar 26, 16:00
2.495
+0.02
(+0.60%)
After-Hours: 20:00
Protalix BioTherapeutics Debt to Equity Ratio: 0.00 for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Inovio Pharmaceuticals Inc | 0.00 |
| Sangamo Therapeutics Inc | 0.00 |
| NexGel Inc | 0.119 |
| AIM ImmunoTech Inc | 0.9382 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 73.42M |
| Total Liabilities (Quarterly) | 30.21M |
| Shareholders Equity (Quarterly) | 43.21M |
| Current Ratio | 2.345 |
| Net Debt Paydown Yield | 2.83% |